Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preparation and pharmaceutical properties of Hangeshashinto oral ointment and its safety and efficacy in Syrian hamsters with 5-fluorouracil-induced oral mucositis.
Ogihara T, Kagawa M, Yamanaka R, Imai S, Itohara K, Hira D, Nakagawa S, Yonezawa A, Ito M, Nakagawa T, Terada T, Matsubara K. Ogihara T, et al. Among authors: kagawa m. J Nat Med. 2023 Jan;77(1):53-63. doi: 10.1007/s11418-022-01645-y. Epub 2022 Aug 24. J Nat Med. 2023. PMID: 36002763 Free PMC article.
Correction: Preparation and pharmaceutical properties of Hangeshashinto oral ointment and its safety and efficacy in Syrian hamsters with 5-fluorouracil-induced oral mucositis.
Ogihara T, Kagawa M, Yamanaka R, Imai S, Itohara K, Hira D, Nakagawa S, Yonezawa A, Ito M, Nakagawa T, Terada T, Matsubara K. Ogihara T, et al. Among authors: kagawa m. J Nat Med. 2024 Jun;78(3):803. doi: 10.1007/s11418-024-01806-1. J Nat Med. 2024. PMID: 38564156 Free PMC article. No abstract available.
Association of variabilities in body mass index and waist circumference with newly achieved remission of metabolic dysfunction-associated fatty liver disease.
Sogabe M, Okahis T, Kagawa M, Sei M, Ueda H, Yokoyama R, Kagemoto K, Tanaka H, Kida Y, Nakamura F, Tomonari T, Okamoto K, Miyamoto H, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: kagawa m. Diabetes Metab Syndr. 2024 May 8;18(5):103036. doi: 10.1016/j.dsx.2024.103036. Online ahead of print. Diabetes Metab Syndr. 2024. PMID: 38754333
Impact of alcohol consumption on metabolic dysfunction-associated fatty liver disease development and remission: A longitudinal cohort study.
Sogabe M, Okahisa T, Kagawa M, Kashihara T, Fujmoto S, Kawaguchi T, Yokoyama R, Kagemoto K, Tanaka H, Kida Y, Tomonari T, Kawano Y, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: kagawa m. Eur J Clin Invest. 2024 Apr 18:e14221. doi: 10.1111/eci.14221. Online ahead of print. Eur J Clin Invest. 2024. PMID: 38634705
Association of metabolic dysfunction-associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study.
Sogabe M, Okahisa T, Kagawa M, Sei M, Ueda H, Yokoyama R, Kagemoto K, Tanaka H, Kida Y, Nakamura F, Tomonari T, Okamoto K, Kawano Y, Miyamoto H, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: kagawa m. J Gastroenterol Hepatol. 2024 Feb 29. doi: 10.1111/jgh.16530. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 38419514
Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis.
Washino S, Shirotake S, Takeshita H, Inoue M, Miura Y, Hyodo Y, Kagawa M, Izumi K, Oyama M, Kawakami S, Saito K, Matsuoka Y, Taniuchi S, Shintani A, Miyagawa T. Washino S, et al. Among authors: kagawa m. Int J Clin Oncol. 2023 Dec;28(12):1651-1658. doi: 10.1007/s10147-023-02406-x. Epub 2023 Sep 2. Int J Clin Oncol. 2023. PMID: 37658926
348 results